Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Here's Why 'Trend' Investors Would Love Betting on Zevra Therapeutics (ZVRA)
Here's Why 'Trend' Investors Would Love Betting on Zevra Therapeutics (ZVRA)

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

Want Better Returns? Don't Ignore These 2 Basic Materials Stocks Set to Beat Earnings
Want Better Returns? Don't Ignore These 2 Basic Materials Stocks Set to Beat Earnings

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's Why
Recent Price Trend in Adherex Technologies (FENC) is Your Friend, Here's Why

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

These 2 Utilities Stocks Could Beat Earnings: Why They Should Be on Your RadarPhoto, wide shot, wide-angle lens,  Gas company, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/07ff6859-914a-4fdd-8473-abdbac8978f6.png
These 2 Utilities Stocks Could Beat Earnings: Why They Should Be on Your Radar

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

What Makes ARS Pharmaceuticals, Inc. (SPRY) a Good Fit for 'Trend Investing'Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
What Makes ARS Pharmaceuticals, Inc. (SPRY) a Good Fit for 'Trend Investing'

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Here's What Could Help Brainsway (BWAY) Maintain Its Recent Price Strength
Here's What Could Help Brainsway (BWAY) Maintain Its Recent Price Strength

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

ArcelorMittal (MT) Shows Fast-paced Momentum But Is Still a Bargain Stock
ArcelorMittal (MT) Shows Fast-paced Momentum But Is Still a Bargain Stock

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

F vs. GM: Which Legacy Automaker Looks Stronger Ahead of Q2 Earnings?Photo, wide shot, wide-angle lens,  Automotive service center, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/c8dbaa5e-abdb-40ac-b919-ed80785b056a.png
F vs. GM: Which Legacy Automaker Looks Stronger Ahead of Q2 Earnings?

As the second-quarter 2025 earnings season approaches for the auto sector, investors are closely watching U.S. auto giants Ford F and General Motors GM to determine which stock is better positioned

Higher NII & Non-Interest Income to Aid U.S. Bancorp's Q2 Earnings
Higher NII & Non-Interest Income to Aid U.S. Bancorp's Q2 Earnings

U.S. Bancorp USB is scheduled to report second-quarter 2025 results on July 17, 2025, before the opening bell. The company is expected to have witnessed year-over-year increases in quarterly

BRO Outperforms Industry, Trades at Premium: How to Play the StockPhoto, wide shot, wide-angle lens,  Reinsurance company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/490045fb-8676-41a9-be7a-bcf4281c7d92.png
BRO Outperforms Industry, Trades at Premium: How to Play the Stock

Shares of Brown & Brown, Inc. BRO have gained 15.7% in the past year, outperforming its industry, the Finance sector and the Zacks S&P 500 composite’s return.The insurer has a market capitalization

Tesla Q2 Earnings Preview: Will the EV Giant Disappoint Again?
Tesla Q2 Earnings Preview: Will the EV Giant Disappoint Again?

Tesla TSLA is set to release second-quarter 2025 results on July 23, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings and revenues is pegged at 40 cents

Are Options Traders Betting on a Big Move in Fifth Third Bancorp Stock?
Are Options Traders Betting on a Big Move in Fifth Third Bancorp Stock?

Investors in Fifth Third Bancorp FITB need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 15, 2025 $47.00 Put had some of the highest

Here's How to Play AbbVie Stock as it Reaches Golden Cross
Here's How to Play AbbVie Stock as it Reaches Golden Cross

AbbVie’s ABBV stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early July. The 50-day moving average is a short-term indicator, while the 200-day moving

Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?
Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and regulatory, that have led investors to bet against the company. The company

Implied Volatility Surging for First Bancorp Stock Options
Implied Volatility Surging for First Bancorp Stock Options

Investors in First Bancorp FBNC need to pay close attention to the stock based on moves in the options market lately. That is because the Sept 19, 2025 $35.00 Put had some of the highest implied

AstraZeneca Meets All Key Goals in Phase III Hypertension Study
AstraZeneca Meets All Key Goals in Phase III Hypertension Study

AstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy of its investigational candidate, baxdrostat, in patients with

Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns
Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns

Investors seeking strong returns may gain by adding stocks with robust liquidity to their portfolios. Liquidity reflects a company's ability to meet its short-term financial obligations. Stocks with